Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

CIOS 2020: The Intersection of Finance and Health Care

October 16, 2020 at 02:00:00 PM · Eastern Time (US & Canada)
About This Webinar

What’s the science and trajectory of cures for our pandemic? Until that is known, finance is reacting to the patient, and the Federal Reserve is propping up the economy, which is not a long-term solution. Gene therapy, biosimilars, the emergence of new technology, and hundreds of thousands of researchers are reliant on venture capitalists, who are now seeing an unpredictable future and are treading more carefully.

Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Executive Director, ISS Media
Webinar hosting presenter
Head of Institutional Investments, FEG Investment Advisors
Nolan is a Managing Principal and Head of Institutional Investments for FEG Investment Advisors, an independent, investment consulting and OCIO provider with nonprofit and corporate clients throughout the United States.

He joined the firm in 2004, and as a member of FEG's Board of Directors and Investment Policy Committee, Nolan’s responsibilities include broader firm and investment strategy.

Nolan was named one of the world’s 10 most influential investment consultants by Chief Investment Officer magazine through the Knowledge Broker award for two consecutive years in 2016 and 2017. He also was named “2011 Nonprofit Consultant of the Year” by Foundation & Endowment Money Management.

Nolan is the current investment committee chair and board of trustees member at the Seven Hills School, and is the past president of the CFA Society of Cincinnati. He received his MBA in Quantitative Analysis and Finance from the University of Cincinnati’s Carl H. Linder College of Business and earned a BSBA in Finance from Georgetown College.
Webinar hosting presenter
Managing Partner, 5AM Venutres
Dr. Parmar serves as a Director on the Boards of Akouos (NASDAQ: AKUS), Entrada, Homology (NASDAQ: FIXX), Rallybio and Vor Biopharma. He previously served as Board Member or Observer for Achaogen (NASDAQ: AKAO), Arvinas (NASDAQ: ARVN), Audentes (NASDAQ: BOLD), Envoy (acquired by Takeda) and scPharmaceuticals (NASDAQ: SCPH) and as Acting VP of Strategy and Corporate Development at Novira (acquired by J&J). Dr. Parmar serves on the Advisory Boards of Harvard Medical School, Penn Medicine, Princeton University’s Department of Molecular Biology, and the Grace Science Foundation. He is a Fellow of the Society of Kauffman Fellows. Prior to 5AM, Dr. Parmar was at Harvard Medical School, where he was an NIH-sponsored M.D./Ph.D. Physician Scientist Fellow in the Harvard-MIT Health Sciences and Technology Program. He holds an A.B. in Molecular Biology and Medieval Studies from Princeton University, a Ph.D. in Experimental Pathology from Harvard University and an M.D. from Harvard Medical School
Preview Download Added by ISS Conference Team at 11:33 AM - Friday - October 9, 2020